Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

103
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
103

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance of Cardiovascular Polygenic Risk Scores in Carotid Stenosis Identification.

medRxiv : the preprint server for health sciences·2026
Same author

Mapping the continuum: polygenic risk of coronary artery disease.

European journal of preventive cardiology·2026
Same author

Gestational Glucose Intolerance and the Risk of Hypertensive Disorders of Pregnancy.

Journal of the American Heart Association·2026
Same author

Hormonal context and lipoprotein(a)-associated venous thromboembolism risk.

European heart journal·2026
Same author

Long-term Penetrance of Disease Variants in Genes Prioritized for Genomic Newborn Screening: Evidence from Adult Biobanks.

medRxiv : the preprint server for health sciences·2026
Same author

Interaction Between Air Pollution and Genetic Predisposition to Blood Pressure and LDL-C on Cardiovascular Events.

European journal of preventive cardiology·2026

Related Experiment Video

Updated: Jun 6, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.4K

Polygenic Prediction of Recurrent Events After Early-Onset Myocardial Infarction.

Maddalena Ardissino1,2,3,4, Elvezia Maria Paraboschi5,6, Samuel A Lambert1,2,7,8

  • 1British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care (M.A.,S.A.L., L.G.K., M.K., M.I., E.D.A., A.S.B.).

Circulation. Genomic and Precision Medicine
|November 29, 2024
PubMed
Summary
This summary is machine-generated.

Genetic risk scores significantly predict recurrent myocardial infarction (MI) in early-onset patients. Adding polygenic scores to traditional factors improves prediction of cardiovascular events after MI.

Keywords:
cardiovascular diseasescoronary artery diseasegenetic risk scoregeneticsheart disease risk factors

More Related Videos

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.2K
Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
14:19

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction

Published on: October 14, 2016

11.5K

Related Experiment Videos

Last Updated: Jun 6, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.4K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.2K
Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
14:19

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction

Published on: October 14, 2016

11.5K

Area of Science:

  • Cardiovascular Genetics
  • Precision Medicine
  • Epidemiology

Background:

  • Myocardial infarction (MI) is a complex condition influenced by both lifestyle and genetic factors.
  • Early-onset MI (before age 45) presents unique challenges for risk prediction and management.
  • Understanding genetic contributions is crucial for improving risk stratification in MI survivors.

Purpose of the Study:

  • To evaluate the predictive value of genetic risk, specifically polygenic scores (PGS), for recurrent cardiovascular events after early-onset MI.
  • To compare the predictive power of PGS against traditional clinical risk factors in this patient cohort.
  • To assess the incremental benefit of incorporating PGS into existing risk prediction models.

Main Methods:

  • The Italian Genetic Study of Early-Onset Myocardial Infarction enrolled patients with MI before age 45.
  • Monogenic variants and a coronary artery disease polygenic score (PGS) were assessed.
  • Cox proportional hazards models were used to analyze the association of clinical variables and PGS with recurrent cardiovascular events over a 19.9-year follow-up.

Main Results:

  • A higher PGS was strongly associated with an increased hazard of recurrent events (HR, 1.21 per SD increase; P=4.04×10⁻⁶).
  • The PGS emerged as the strongest determinant of recurrent event risk, outperforming clinical factors.
  • Adding PGS to clinical risk factors significantly improved the predictive performance (C-index) for recurrent events.

Conclusions:

  • Polygenic scores are powerful predictors of event recurrence in patients with early-onset MI.
  • Incorporating genetic risk information, via PGS, enhances the discrimination of cardiovascular event prediction models.
  • These findings support the potential of genetic profiling for personalized risk assessment and secondary prevention strategies in younger MI patients.